Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 106 to 120 of 235 results for radiotherapy

  1. Cryotherapy as a primary treatment for prostate cancer (IPG145)

    Evidence-based recommendations on cryotherapy as a primary treatment for prostate cancer. This involves using cold temperature to freeze and destroy cancer tissue as a first treatment for cancer that hasn't spread far from the prostate.

    Interventional procedures guidance
    Published
    23 November 2005
    View recommendations

    Sections for IPG145

  2. Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours (TA265)

    Evidence-based recommendations on denosumab (XGEVA) for the prevention of skeletal-related events in adults with bone metastases from solid tumours

    Technology appraisal guidance
    Published
    24 October 2012
    View recommendations

    Sections for TA265

  3. High-intensity focused ultrasound for prostate cancer (IPG118)

    Evidence-based recommendations on high-intensity focused ultrasound for treating prostate cancer. This involves inserting a probe through the rectum that gives out a beam of ultrasound to heat and destroy the cancerous prostate tissue.

    Interventional procedures guidance
    Published
    23 March 2005
    View recommendations

    Sections for IPG118

  4. Percutaneous radiofrequency ablation for primary or secondary lung cancers (IPG372)

    Evidence-based recommendations on percutaneous radiofrequency ablation for primary or secondary lung cancers. This involves inserting 1 or more electrodes (needle-like probes) through the chest into the lung and using an electrical current to produce heat to destroy the cancer cells.

    Interventional procedures guidance
    Published
    15 December 2010
    View recommendations

    Sections for IPG372

  5. Intensity modulated radiotherapy for breast cancer [ID16]

    Discontinued [GID-TAG390]

    Technology appraisal guidance
    Discontinued

  6. Intensity modulated radiotherapy for prostate cancer [ID17]

    Discontinued [GID-TAG396]

    Technology appraisal guidance
    Discontinued

  7. Photodynamic therapy for advanced bronchial carcinoma (IPG87)

    Evidence-based recommendations on photodynamic therapy for advanced bronchial carcinoma. This involves giving the patient something that makes them sensitive to light, then using special equipment to shine light onto the cancer to activate the substance and destroy some of the cancer.

    Interventional procedures guidance
    Published
    25 August 2004
    View recommendations

    Sections for IPG87

  8. Intensity modulated radiotherapy for head and neck cancer [ID15]

    Discontinued [GID-TAG397]

    Technology appraisal guidance
    Discontinued

  9. Further research on endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia could include the publication of collaborative audit data. Reports should separate outcomes for different groups of patients; in particular for patients with primary neuromuscular dysfunction alone, those with associated phargyngeal diverticula and those with dysphagia caused by radiotherapy. Outcome measures should include dysphagia scores, quality of life, long-term outcomes and the need for further treatment. All complications should be reported. NICE may update this guidance on publication of further evidence.

    associated phargyngeal diverticula and those with dysphagia caused by radiotherapy. Outcome measures should include dysphagia scores,...

    Research recommendation
    Published
    6 April 2016

  10. Supporting the health and care system in improving productivity

    Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.

  11. Supporting the health and care system in improving productivity

    Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.

  12. In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers enable patients to select more effective treatment, and improve their outcomes, compared with treatment selected without biomarkers?

    Any explanatory notes(if applicable) Response to surgery or radiotherapy is difficult to predict for individuals. There is variation...

    Research recommendation
    Published
    9 June 2015

  13. Cyanoacrylate instillation for occlusion of parotid sinuses (IPG42)

    Evidence-based recommendations on cyanoacrylate instillation for occlusion of parotid sinuses. This involves injecting a solution of lipiodiol and cyanoacrylate via the sinus into the parotid gland, sealing the sinus.

    Interventional procedures guidance
    Published
    25 February 2004
    View recommendations

    Sections for IPG42

  14. Endoscopic transsphenoidal pituitary adenoma resection (IPG32)

    Evidence-based recommendations on endoscopic transsphenoidal pituitary adenoma resection. This involves inserting a tube into the nostril towards the tumour base and removing the tumour using specialised surgical instruments.

    Interventional procedures guidance
    Published
    17 December 2003
    View recommendations

    Sections for IPG32

  15. Accessing NHS care and treatment recommended by NICE (ECD4)

    Accessing NHS care and treatment recommended by NICE